Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Liabilities from Discontinued Operations (2024 - 2025)

Historic Liabilities from Discontinued Operations for Standard Biotools (LAB) over the last 2 years, with Q3 2025 value amounting to $22.2 million.

  • Standard Biotools' Liabilities from Discontinued Operations changed N/A to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.2 million, marking a year-over-year change of. This contributed to the annual value of $20.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Liabilities from Discontinued Operations is $22.2 million.
  • In the past 5 years, Standard Biotools' Liabilities from Discontinued Operations registered a high of $22.2 million during Q3 2025, and its lowest value of $18.0 million during Q2 2025.